Taiwan Liposome Co.

$80$125

Taiwan Liposome Co. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company’s therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.

Report ID:

UMHE21220

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

Taiwan

Geography:

, , ,

Clear
  Get a Free Sample
SKU: UMHE21220 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Growth Strategy
4.    Key Products & Services Offered
5.    Product Portfolio
6.    SWOT Analysis
7. Company Revenue Split
8.    Key Financials
9. Recent Developments
9.1 Partnerships”

Companies Mentioned

“3SBio
Jixi Biotechnology Partners
Birdie”